Amalgamated Bank lowered its position in Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 0.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 224,433 shares of the biotechnology company’s stock after selling 2,060 shares during the quarter. Amalgamated Bank owned about 0.07% […]